Scholarlink

<p>Liquid biopsies are increasingly important tools for precision oncology. Although their ability to detect the minute amounts of cancer biomarkers present in biofluids is improving, limitations remain regarding accurate detection of certain pathologies, analytical validation, application range and broad clinical utility. Emerging methods harness multi-omic data from a range of circulating analytes that can be released from various sources via distinct biological processes, thereby providing complementary and more sensitive information. Modulating the cellular release of these analytes and their half-lives in blood can be exploited to inform on cancer detection, treatment selection, response and/or toxicity. Simultaneously, efforts to miniaturize liquid biopsies to capitalize on their minimally invasive nature will accelerate turnaround time and enable continuous and ideally remote monitoring of circulating analytes. Together, these advances towards next-generation liquid biopsies will substantially improve patient experience.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Advancing the applications of liquid biopsies in oncology

  • 期刊论文

  • 发表日期：

    2026年5月29日

查看全文
  • Sara Valpione,
  • Alexandra Clipson,
  • Dominic G. Rothwell,
  • Caroline Dive,
  • Florent Mouliere

摘要

Liquid biopsies are increasingly important tools for precision oncology. Although their ability to detect the minute amounts of cancer biomarkers present in biofluids is improving, limitations remain regarding accurate detection of certain pathologies, analytical validation, application range and broad clinical utility. Emerging methods harness multi-omic data from a range of circulating analytes that can be released from various sources via distinct biological processes, thereby providing complementary and more sensitive information. Modulating the cellular release of these analytes and their half-lives in blood can be exploited to inform on cancer detection, treatment selection, response and/or toxicity. Simultaneously, efforts to miniaturize liquid biopsies to capitalize on their minimally invasive nature will accelerate turnaround time and enable continuous and ideally remote monitoring of circulating analytes. Together, these advances towards next-generation liquid biopsies will substantially improve patient experience.